Rincell-1 Otic Neural Progenitor Cell-Based Therapy (Rinri Therapeutics)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameRincell-1 Otic Neural Progenitor Cell-Based Therapy (Rinri Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Otic neural progenitor cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPresbycusisHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRinri Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRinri Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsPresbycusisHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A